<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Broere, A.</title>
    <link>http://repub.eur.nl/res/aut/11621/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME (Article)</title>
      <link>http://repub.eur.nl/res/pub/8977/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Experimental evidence indicates that the renal circulation is more
          sensitive to the effects of nitric oxide (NO) synthesis inhibition than
          other vascular beds. To explore whether in men the NO-mediated vasodilator
          tone is greater in the renal than in the systemic circulation, the effects
          of three different intravenous infusions of NG-nitro-L-arginine methyl
          ester (L-NAME; 1, 5, and 25 microg. kg-1. min-1 for 30 min) or placebo on
          mean arterial pressure (MAP), systemic vascular resistance (SVR), renal
          blood flow (RBF), renal vascular resistance (RVR), glomerular filtration
          rate (GFR), and fractional sodium and lithium excretion (FENa and FELi)
          were studied in 12 healthy subjects, each receiving randomly two of the
          four treatments on two different occasions. MAP was measured continuously
          by means of the Finapres device, and stroke volume was calculated by a
          model flow method. GFR and RBF were estimated from the clearances of
          radiolabeled thalamate and hippuran. Systemic and renal hemodynamics were
          followed for 2 h after start of infusions. During placebo, renal and
          systemic hemodynamics and FENa and FELi remained stable. With the low and
          intermediate L-NAME doses, maximal increments in SVR and RVR were similar:
          20.4 +/- 19.6 and 23.5 +/- 16.0%, respectively, with the low dose and 31.4
          +/- 26.7 and 31.2 +/- 14.4%, respectively, with the intermediate dose
          (means +/- SD). With the high L-NAME dose, the increment in RVR was
          greater than the increment in SVR. Despite a decrease in RBF, FENa and
          FELi did not change with the low L-NAME dose, but they decreased by 31.2
          +/- 11.0 and 20.2 +/- 6.3%, respectively, with the intermediate dose and
          by 70.8 +/- 8.1 and 31.5 +/- 15.9% with the high L-NAME dose,
          respectively. It is concluded that in men the renal circulation is not
          more sensitive to the effects of NO synthesis inhibition than the systemic
          circulation and that the threshold for NO synthesis inhibition to produce
          antinatriuresis is higher than the threshold level to cause renal
          vasoconstriction.</description>
    </item>
  </channel>
</rss>